Defensive Medicine Common Among Surgeons, Radiologists

This article originally appeared here.
Share this content:
Defensive Medicine Common Among Surgeons, Radiologists
Defensive Medicine Common Among Surgeons, Radiologists

(HealthDay News) -- Defensive medicine is commonly practiced among surgeons and radiologists in Austria, according to a study published online Jan. 6 in the Journal of Evaluation in Clinical Practice.

Michael Osti, M.D., from the Academic Hospital Feldkirch in Austria, and Johannes Steyrer, Ph.D., from the Vienna University of Economics and Business, surveyed orthopedic and trauma surgeons as well as radiologists form public hospitals to quantify the practice of defensive medicine.

The researchers found that the prevalence of defensive medicine was 97.7 percent. More than one-quarter of all diagnostic examinations (28 percent) are ordered by orthopedic or trauma surgeons for defensive reasons (on average, 19.6 investigations per month for the average surgeon). Participants report receiving 1.4 liability claims per month. The majority of doctors (81 percent) request additional diagnostic procedures for defensive purposes when treating high-risk patients. In radiology, the time spent on defensive practice is 9.2 hours per month, and among orthopedic and trauma surgeons, defensive practice equals 17 and 18 percent of total working time, respectively.

"Our results indicate the urgent necessity for confrontation with and solution for the increasing effort of self-protection within the health care system," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »